Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05285306 · ClinicalTrials.gov registry record · NA

Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention

A NA study of Anxiety, sponsored by Duke University.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT05285306: Completed NA study of Anxiety, sponsored by Duke University.

NCT05285306 is a NA study of Anxiety that has completed, run by Duke University. The registered enrollment target is 16 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05285306, a NA study of Anxiety, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the feasibility and acceptability of a brief coping skills training program addressing anxiety and pain related to surveillance pelvic examinations for female gynecologic cancer survivors.

Primary Outcome

The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).

Conditions Studied

Interventions

  • BEHAVIORAL PEACE Program

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2022-03-21
Est. Completion 2022-09-02
Phase NA
Duke University

1,725 total trials

What the finished NCT05285306 record still lists

NCT05285306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which PEACE Program is the first listed.

NCT05285306 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05285306 about?

NCT05285306 is a clinical study titled "Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention". The purpose of this study is to test the feasibility and acceptability of a brief coping skills training program addressing anxiety and pain related to surveillance pelvic examinations for female gynecologic cancer survivors.

What is the current status of trial NCT05285306?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-03-21. Estimated completion is 2022-09-02.

What conditions does trial NCT05285306 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT05285306?

The interventions under investigation include: PEACE Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05285306?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05285306 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05285306's enrollment target sits among peer trials

16 342nd of 364 higher than 21 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05285306, the US trial registry maintained by the National Library of Medicine. NCT05285306 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.